Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for GBS Inc. (GBS : NSDQ)
 
 • Company Description   
GBS Inc. is a life sciences company. It engages in developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. GBS Inc. is based in NEW YORK.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.95 Daily Weekly Monthly
20 Day Moving Average: 1,360,841 shares
Shares Outstanding: 12.38 (millions)
Market Capitalization: $48.91 (millions)
Beta:
52 Week High: $14.24
52 Week Low: $2.44
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 25.40% 24.04%
12 Week -30.09% -34.52%
Year To Date -46.62% -52.73%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
-
-
-,- -
-
ph: -
fax: -
None None
 
 • General Corporate Information   
Officers
- - -
- - -
- - -
- - -
- - -

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 36151G105
SIC: -
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/21
Next Expected EPS Date: 08/13/21
Share - Related Items
Shares Outstanding: 12.38
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $48.91 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/21  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -17.39%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -87.99%
ROE
03/31/21 - -
12/31/20 - -
09/30/20 - -
ROA
03/31/21 - -
12/31/20 - -
09/30/20 - -
Current Ratio
03/31/21 - -
12/31/20 - -
09/30/20 - -
Quick Ratio
03/31/21 - -
12/31/20 - -
09/30/20 - -
Operating Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Net Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Pre-Tax Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Book Value
03/31/21 - -
12/31/20 - -
09/30/20 - -
Inventory Turnover
03/31/21 - -
12/31/20 - -
09/30/20 - -
Debt-to-Equity
03/31/21 - -
12/31/20 - -
09/30/20 - -
Debt-to-Capital
03/31/21 - -
12/31/20 - -
09/30/20 - -
 

Powered by Zacks Investment Research ©